Proteome Sciences plc
http://www.proteomics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Proteome Sciences plc
INTERVIEW: Pre Diagnostics takes new approach to Alzheimer's blood test
As the focus in Alzheimer's moves ever more towards treating early disease, there has been a parallel upswing in diagnostics companies and researchers developing blood tests for Alzheimer's disease. One firm, Norway's Pre Diagnostics, is taking a different approach that it believes will give it the edge over its rivals. Madeleine Armstrong spoke to chief scientific officer Frank Swenson
Biomarker study raises hopes for Alzheimer's blood test
Research led by UK company Proteome Sciences and King's College London could lead to a clinical blood test for Alzheimer's disease within five years, and, more immediately, could be helpful in selecting patients for clinical trials of new drugs for the condition. Given the enormous failure rate for drug trials in this indication, it is thought that recruiting patients to drug trials earlier in the disease process before irreversible damage is caused could prove more effective, especially as it is thought that Alzheimer's can be asymptomatic for up to ten years.
SensiDerm Assay Could Fill Void For Non-Animal Allergy Test In EU
U.K-based firm Proteome Sciences eyes the niche for a non-animal sensitivity test. Cosmetics Europe names its SensiDerm assay a first priority for funding.
Proteome advances CK1D inhibitors in Tau approach to Alzheimer's
The proteomics and peptidomics company Proteome Sciences is looking for pharma company partners to take its novel CK1D inhibitors into the clinic in Alzheimer's disease after achieving in vivo proof of concept for the oral compounds.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Electrophoretics Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice